Seguir
Kristin L Andrejko
Título
Citado por
Citado por
Año
Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection—California, February–December 2021
KL Andrejko
MMWR. Morbidity and mortality weekly report 71, 2022
183*2022
School closures reduced social mixing of children during COVID-19 with implications for transmission risk and school reopening policies
JR Head, KL Andrejko, Q Cheng, PA Collender, S Phillips, A Boser, ...
Journal of the Royal Society Interface 18 (177), 20200970, 2021
80*2021
Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
KL Andrejko, J Pry, JF Myers, NP Jewell, J Openshaw, J Watt, S Jain, ...
Clinical Infectious Diseases, 2021
64*2021
Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression …
K Andrejko, B Ratnasiri, WP Hausdorff, R Laxminarayan, J Lewnard
The Lancet Microbe, 2021
582021
Prevalence and clinical profile of severe acute respiratory syndrome coronavirus 2 infection among farmworkers, California, USA, June–November 2020
JA Lewnard, AM Mora, O Nkwocha, K Kogut, SA Rauch, N Morga, ...
Emerging infectious diseases 27 (5), 1330, 2021
32*2021
Predictors of SARS-CoV-2 infection following high-risk exposure
KL Andrejko, J Pry, J Myers, K Openshaw, J Watt, N Birkett, JL DeGuzman, ...
Clinical Infectious Diseases, 2021
31*2021
Determinants of uptake of intermittent preventive treatment during pregnancy: a review
E Roman, K Andrejko, K Wolf, M Henry, S Youll, L Florey, E Ferenchick, ...
Malaria Journal 18, 1-9, 2019
272019
The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review
KL Andrejko, RC Mayer, S Kovacs, E Slutsker, E Bartlett, KR Tan, ...
Travel medicine and infectious disease 27, 20-26, 2019
232019
Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations
JR Head, KL Andrejko, JV Remais
The Lancet Regional Health–Americas 5, 2022
172022
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study
KL Andrejko, JF Myers, N Fukui, L Nelson, R Zhao, J Openshaw, JP Watt, ...
Vaccine 41 (10), 1649-1656, 2023
112023
Health-Economic Value of Vaccination Against Group A Streptococcus in the United States
K Andrejko, LK Whittles, JA Lewnard
Clinical Infectious Diseases 74 (6), 983-992, 2022
102022
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021–2022 influenza season
KL Andrejko, JF Myers, J Openshaw, N Fukui, S Li, JP Watt, EL Murray, ...
Vaccine 41 (6), 1190-1197, 2023
92023
Longitudinal social contacts among school-aged children during the COVID-19 pandemic: the Bay Area Contacts among Kids (BACK) study
KL Andrejko, JR Head, JA Lewnard, JV Remais
BMC infectious diseases 22 (1), 242, 2022
92022
Waning of 2-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection accounting for depletion-of-susceptibles bias
KL Andrejko, JM Pry, JF Myers, M Mehrotra, K Lamba, E Lim, N Fukui, ...
American journal of epidemiology 192 (6), 895-907, 2023
8*2023
Association of pneumococcal serotype with susceptibility to antimicrobial drugs: a systematic review and meta-analysis
K Andrejko, B Ratnasiri, JA Lewnard
Clinical Infectious Diseases, 2021
72021
WHO Technical Expert Consultation Report on Optimization of PCV Impact: Review of Evidence and Programmatic Considerations to Inform Policy
K Andrejko, D Hosangadi, O Cohen, C Adam L, BA Flasche, P McIntyre, ...
6*2017
Contribution and quality of mathematical modeling evidence in world health organization guidelines: A systematic review
NC Lo, K Andrejko, P Shukla, T Baker, VI Sawin, SL Norris, JA Lewnard
Epidemics 39, 100570, 2022
52022
Biodigester Cookstove Interventions and Child Diarrhea in Semirural Nepal: A Causal Analysis of Daily Observations
HK Amato, C Hemlock, KL Andrejko, AR Smith, NS Hejazi, AE Hubbard, ...
Environmental Health Perspectives 130 (1), 2022
52022
Outpatient Visits and Antibiotic Use Due to Higher-Valency Pneumococcal Vaccine Serotypes
LM King, KL Andrejko, S Kabbani, SY Tartof, LA Hicks, AL Cohen, ...
The Journal of Infectious Diseases, jiae142, 2024
2*2024
1173. Risk of Pneumococcal Disease and Rate of Pneumococcal Vaccination Among Medicare Beneficiaries Aged 65 Years and Older Residing in Long-Term Care Facilities—United …
M Kobyashi, K Andrejko, L Zielinski, A Lindaas, H Cha, B Lufkin, ...
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1013, 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20